Molecular and Translational Pharmacology
2200 København N.
Alexander Hovard Sparre-Ulrich has a part-time position as assistant professor at the Department of Biomedical Sciences (BMI). He actively teaches within the field of basic pharmacology.
Alexander is co-founder and CEO of Antag Therapeutics that is based on years of collaborative research from the University of Copenhagen with the focus on novel treatments for dietary-related metabolic diseases.
BMI and Antag Therapeutics collaborates on a variety of research projects with the aim of generating new knowledge that can be used in the prevention and treatment of diseases.